Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 2/20 | 0.48 |
| ▸ | NPY1R | P25929 | 1/20 | 0.35 |
| ▸ | NPY2R | P49146 | 1/20 | 0.35 |
| ▸ | NPY4R | P50391 | 1/20 | 0.35 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15186983 | 0.98 | GSR (0.50) | GSRNPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL31387966 | 0.95 | — | — | |
| SCHEMBL13515822 | 0.84 | ADH1A (0.33) | GSR | |
| SCHEMBL15186982 | 0.81 | ADH1A (0.36) | GSR | |
| SCHEMBL4543413 | 0.78 | GSR (0.42) | GSRNPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL16318606 | 0.76 | GSR (0.44) | GSRNPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL16318639 | 0.76 | GSR (0.44) | GSRNPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL16318622 | 0.76 | GSR (0.44) | GSRNPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL5974055 | 0.75 | NPY1R (0.40) | GSRNPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL27888978 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117940432-A | Camptothecins compound, preparation method and application thereof | 上海弼领生物技术有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-116769648-A | Fermentation medium and method for producing rapamycin through fermentation | 丽珠集团福州福兴医药有限公司 | 2023-09-19 | — | — | CN | disclosed |
| US-11180585-B2 | Film touch sensor and structure including the same | DONGWOO FINE-CHEM CO., LTD. (KR) | 2021-11-23 | — | — | US | disclosed |
| US-20210277156-A1 | FILM TOUCH SENSOR AND STRUCTURE INCLUDING THE SAME | DONGWOO FINE-CHEM CO., LTD. (KR) | 2021-09-09 | — | — | US | disclosed |
| EP-3612512-A1 | ANTIMICROBIAL AGENTS | The University Of Warwick (GB) | 2020-02-26 | — | — | EP | disclosed |
| US-20200048183-A1 | ANTIMICROBIAL AGENTS | UNIV WARWICK (GB) | 2020-02-13 | — | — | US | disclosed |
| WO-2018193273-A1 | ANTIMICROBIAL AGENTS | THE UNIVERSITY OF WARWICK (GB) | 2018-10-25 | — | — | WO | disclosed |
| EP-1091971-B1 | POLYKETIDE SYNTHESIS | BIOTICA TECH LTD (GB) | 2010-03-17 | — | — | EP | disclosed |
| US-7390895-B2 | Production of polyketides and other natural products | BIOTICA TECHNOLOGY LIMITED (GB) | 2008-06-24 | — | — | US | disclosed |
| US-20080021211-A1 | PRODUCTION OF POLYKETIDES AND OTHER NATURAL PRODUCTS | BIOTICA TECHNOLOGY LIMITED (GB) | 2008-01-24 | — | — | US | disclosed |
| WO-2002097082-A2 | ENGINEERED BIOSYNTHESIS OF NOVEL POLYENES | UNIVERSITY COLLEGE DUBLIN (IE) | 2002-12-05 | — | — | WO | disclosed |
| WO-2002024736-A9 | POLYNUCLEOTIDES AND POLYPEPTIDES ASSOCIATED WITH ANTIBIOTIC BIOSYNTHESIS AND USES THEREFOR | UNIV QUEENSLAND (AU) | 2002-11-07 | — | — | WO | disclosed |
| WO-2002024736-A1 | POLYNUCLEOTIDES AND POLYPEPTIDES ASSOCIATED WITH ANTIBIOTIC BIOSYNTHESIS AND USES THEREFOR | THE UNIVERSITY OF QUEENSLAND (AU) | 2002-03-28 | — | — | WO | disclosed |
| EP-1183369-A1 | POLYKETIDES AND THEIR SYNTHESIS | Biotica Technology Limited (GB) | 2002-03-06 | — | — | EP | disclosed |
| EP-1180110-A1 | 13-METHYL-ERYTHROMYCIN DERIVATIVES | Pfizer Products Inc. (US) | 2002-02-20 | — | — | EP | disclosed |
| WO-2001068867-A1 | POLYKETIDES AND THEIR SYNTHESIS | BIOTICA TECHNOLOGY LIMITED (GB) | 2001-09-20 | — | — | WO | disclosed |
| EP-1091971-A2 | POLYKETIDES AND THEIR SYNTHESIS | Biotica Technology Limited (GB) | 2001-04-18 | — | — | EP | disclosed |
| WO-2000071557-A1 | 13-METHYL-ERYTHROMYCIN DERIVATIVES | PFIZER PRODUCTS INC. (US) | 2000-11-30 | — | — | WO | disclosed |
| WO-2000000500-A2 | POLYKETIDES AND THEIR SYNTHESIS | BIOTICA TECHNOLOGY LIMITED (GB) | 2000-01-06 | — | — | WO | disclosed |
| EP-0002872-A1 | Process for preparing acylated esters of hydroxy carboxylates | THE PROCTER & GAMBLE COMPANY (US) | 1979-07-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200048183-A1 | ANTIMICROBIAL AGENTS | C3AR1, HCAR3, C5AR1 | GSR 723/4885NPY1R 281/4885NPY2R 599/4885 |
| US-20080021211-A1 | PRODUCTION OF POLYKETIDES AND OTHER NATURAL PRODUCTS | FKBP14, FKBP4, FKBP2 | GSR 4420/4885NPY1R 2433/4885NPY2R 2333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.